200,000+ products from a single source!
sales@angenechem.com
CAS No: 1224844-38-5 Catalog No: AG0017AM MDL No:MFCD22124893
Title | Journal |
---|---|
Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth. | Oncotarget 20160209 |
Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120501 |
The translational landscape of mTOR signalling steers cancer initiation and metastasis. | Nature 20120222 |
ATP-competitive inhibitors of mTOR: an update. | Current medicinal chemistry 20110101 |
mTOR Mediated Anti-Cancer Drug Discovery. | Drug discovery today. Therapeutic strategies 20090101 |
© 2019 Angene International Limited. All rights Reserved.